Suellen Curkendall

Summary

Affiliation: Thomson Reuters
Country: UK

Publications

  1. pmc Insulin use and persistence in patients with type 2 diabetes adding mealtime insulin to a basal regimen: a retrospective database analysis
    Machaon M Bonafede
    Outcomes Research, Thomson Reuters Inc, 37 Lowell Street, Andover MA 01810, USA
    BMC Endocr Disord 11:3. 2011
  2. doi request reprint Productivity losses among treated depressed patients relative to healthy controls
    Suellen Curkendall
    Thomson Reuters, 4301 Connecticut Avenue NW, Suite 330, Washington, DC 20008, USA
    J Occup Environ Med 52:125-30. 2010
  3. doi request reprint Potential health care cost savings associated with early treatment of multiple sclerosis using disease-modifying therapy
    Suellen M Curkendall
    Thomson Reuters, Washington, DC 20008, USA
    Clin Ther 33:914-25. 2011
  4. doi request reprint The direct and indirect cost burden of acute coronary syndrome
    Stephen S Johnston
    Thomson Reuters, Washington, DC, USA
    J Occup Environ Med 53:2-7. 2011

Collaborators

Detail Information

Publications4

  1. pmc Insulin use and persistence in patients with type 2 diabetes adding mealtime insulin to a basal regimen: a retrospective database analysis
    Machaon M Bonafede
    Outcomes Research, Thomson Reuters Inc, 37 Lowell Street, Andover MA 01810, USA
    BMC Endocr Disord 11:3. 2011
    ..abstract:..
  2. doi request reprint Productivity losses among treated depressed patients relative to healthy controls
    Suellen Curkendall
    Thomson Reuters, 4301 Connecticut Avenue NW, Suite 330, Washington, DC 20008, USA
    J Occup Environ Med 52:125-30. 2010
    ..Estimate the productivity-related cost of depression in an employed population...
  3. doi request reprint Potential health care cost savings associated with early treatment of multiple sclerosis using disease-modifying therapy
    Suellen M Curkendall
    Thomson Reuters, Washington, DC 20008, USA
    Clin Ther 33:914-25. 2011
    ..Clinical trials have shown that treatment with disease-modifying therapies (DMTs), such as interferon, at the time of clinically isolated syndrome can delay the onset of multiple sclerosis (MS)...
  4. doi request reprint The direct and indirect cost burden of acute coronary syndrome
    Stephen S Johnston
    Thomson Reuters, Washington, DC, USA
    J Occup Environ Med 53:2-7. 2011
    ..Quantify the incremental health care costs and workplace absence and short-term disability costs, to payers and employers, of patients hospitalized for acute coronary syndrome (ACS)...